The Oncofertility Consortium® is excited to announce that one of our postdoctoral fellows, Lisa Campo-Engelstein, has published an article in the March 2010 issue of the Journal of Clinical Oncology. The article, titled “Including Fertility Preservation Treatment: Consistency and Fairness in Insurance Coverage for Iatrogenic Conditions Resulting from Cancer Treatment,” explores the issue of insurance coverage for fertility preservation for cancer patients.
In the article, Dr. Campo-Engelstein discusses how insurance companies currently cover treatment for iatrogenic conditions resulting from cancer treatment that could be perceived as elective when “naturally” occurring, such as breast reconstruction following mastectomy and wigs for alopecia. Looking at female cancer patients, Dr. Campo-Engelstein explores similarities between these iatrogenic conditions and iatrogenic infertility. She argues that, because treatment for iatrogenic infertility does not differ in morally significant ways from treatment for these other iatrogenic conditions that are covered, then it should also be covered if insurance companies want to maintain consistency and promote fairness.
The contents of the Oncofertility Consortium Blog are for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
965 Wilson Road, Room A626B
East Lansing, MI 48824-1316
Phone: 1 (517) 884 6434
Email: oncofert@msu.edu
NOTICE:
Ownership of this website has been transferred from Northwestern University to Michigan State University. Please note that some site information may be inaccurate while adjustments to reflect this organizational change are made.